SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-008048
Filing Date
2022-01-27
Accepted
2022-01-27 08:01:36
Documents
14
Period of Report
2022-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224636d1_8k.htm   iXBRL 8-K 29777
2 EXHIBIT 99.1 tm224636d1_ex99-1.htm EX-99.1 11697
3 EXHIBIT 99.2 tm224636d1_ex99-2.htm EX-99.2 10598
  Complete submission text file 0001104659-22-008048.txt   229287

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bstg-20220125.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstg-20220125_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstg-20220125_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm224636d1_8k_htm.xml XML 3276
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 22559922
SIC: 3841 Surgical & Medical Instruments & Apparatus